Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LGF.B
9676
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $304K | ﹤0.01% |
34,390
+6,506
| +23% | +$74.1K |
|
9677
Belden
BDC
$5.31B
| $303K | ﹤0.01% |
5,682
-33,774
| -86% | -$1.81M |
|
9678
CALL
DocGo
DCGO
$65.9M
| $303K | ﹤0.01% |
42,400
+25,000
| +144% | +$182K |
|
9679
PUT
Red Robin
RRGB
$192M
| $303K | ﹤0.01% |
37,700
-30,900
| -45% | -$333K |
|
9680
CALL
SEI Investments
SEIC
$12.8B
| $303K | ﹤0.01% |
+5,600
| New | +$315K |
|
9681
PUT
Champion Homes
SKY
$5.13B
| $303K | ﹤0.01% |
6,400
-62,900
| -91% | -$3.24M |
|
9682
CALL
Global X SuperDividend REIT ETF
SRET
$230M
| $303K | ﹤0.01% |
12,567
+4,634
| +58% | +$119K |
|
9683
Cato Corp
CATO
$67.9M
| $302K | ﹤0.01% |
26,029
+14,438
| +125% | +$190K |
|
9684
CALL
Genius Sports
GENI
$2.33B
| $302K | ﹤0.01% |
134,000
-34,500
| -20% | -$116K |
|
9685
Mercury Systems
MRCY
$6.67B
| $302K | ﹤0.01% |
4,698
-85,324
| -95% | -$5.09M |
|
|
MSB
9686
PUT
Mesabi Trust
MSB
$301M
| $302K | ﹤0.01% |
12,300
-10,100
| -45% | -$263K |
|
9687
State Street DoubleLine Short Duration Total Return Tactical ETF
STOT
$507M
| $302K | ﹤0.01% |
6,473
-21,604
| -77% | -$1.02M |
|
9688
CALL
Cambria Tail Risk ETF
TAIL
$146M
| $302K | ﹤0.01% |
+17,200
| New | +$292K |
|
9689
Vanguard Total International Stock ETF
VXUS
$164B
| $302K | ﹤0.01% |
5,845
+2,140
| +58% | +$119K |
|
9690
Accel Entertainment
ACEL
$1.01B
| $301K | ﹤0.01% |
28,301
-114,675
| -80% | -$1.28M |
|
9691
Fidus Investment
FDUS
$744M
| $301K | ﹤0.01% |
17,248
-12,685
| -42% | -$245K |
|
9692
iShares Morningstar Multi-Asset Income ETF
IYLD
$126M
| $301K | ﹤0.01% |
+15,191
| New | +$317K |
|
9693
Kinsale Capital Group
KNSL
$8.64B
| $301K | ﹤0.01% |
1,312
-4,394
| -77% | -$972K |
|
9694
CALL
Nektar Therapeutics
NKTR
$2.49B
| $301K | ﹤0.01% |
5,273
-12,854
| -71% | -$811K |
|
|
IFLN
9695
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$307M
| $301K | ﹤0.01% |
17,841
-44,943
| -72% | -$790K |
|
9696
Clockwise U.S. Core Equity ETF
TIME
$15.6M
| $301K | ﹤0.01% |
17,538
-2,562
| -13% | -$52.6K |
|
|
BURU
9697
PUT
DELISTED
NUBURU INC
BURU
| $300K | ﹤0.01% |
151
-79
| -34% | -$156K |
|
9698
CALL
Denison Mines
DNN
$2.92B
| $300K | ﹤0.01% |
308,800
-43,400
| -12% | -$55.7K |
|
9699
SPDR Gold MiniShares Trust
GLDM
$30B
| $300K | ﹤0.01% |
8,367
-1,613
| -16% | -$60K |
|
9700
PUT
MGIC Investment
MTG
$6.39B
| $300K | ﹤0.01% |
23,800
+300
| +1% | +$3.94K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.